机构:[a]Department of Oncology, The Second Affiliated Hospital of Soochow University, Suzhou,[b]Department of Clinical Laboratory, The Second Affiliated Hospital of Soochow University, Suzhou,[c]Department of Hematology, The Second Affiliated Hospital of Soochow University, Suzhou,[d]Institute of Radiotherapy & Oncology, Soochow University, Suzhou, China
Background/Aims: Interferon regulatory factor 1 (IRF-1) has been shown to function as a transcriptional activator or repressor of a variety of target genes. However, its upstream, non coding RNA-related regulatory capacity remains unknown. In this study, we focus on the miRNA-associated single nucleotide polymorphisms (SNPs) in the 3'untranslated region (UTR) of IRF-1 to further investigate the functional relationship and potential diagnostic value of the SNPs and miRNAs among Chinese gastric cancer (GC) patients. Methods: We performed a case control study with 819 GC patients and 756 cancer-free controls. Genotyping by real-time PCR assay, cell transfection, and the dual luciferase reporter assay were used in our study, and the 5-year overall survival rate and relapse-free survival rate in different groups were investigated. Results: We found that patients suffering from Helicobacter pylori (Hp) infection were the susceptible population compared to controls. SNP rs56288038 (C/G) in IRF-1 3'UTR was involved in the occurrence of GC by acting as a tumor promoter factor. SNP rs56288038 (C/G) could be up-regulated by miR-502-5p, which caused a down-regulation of IRF-1 in cell lines and decreased apoptosis induced by IFN-gamma. Carrying the G genotype was related to significantly low expression of IRF-1 and Hp infection, poor differentiation, big tumor size, invasion depth, as well as the high probability of metastasis, and moreover, the C/G SNP was associated with shorter survival of GC patients with five years of follow-up study. Conclusions: our findings have shown that the SNP rs56288038 (C/G) in IRF-1 3'UTR acted as a promotion factor in GC development through enhancing the regulatory role of miR-502-5p in IRF-1 expression. (C) 2016 The Author(s) Published by S Karger AG, Basel
基金:
Jiangsu Key Laboratory of Medical Science and Laboratory Medicine (Grant No. JSKLM-2014-004) to BW.
第一作者机构:[a]Department of Oncology, The Second Affiliated Hospital of Soochow University, Suzhou,
共同第一作者:
通讯作者:
通讯机构:[*1]Department of Oncology, The Second Affiliated Hospital of Soochow University,1055 Sanxiang Road, Suzhou, Jiangsu, 215004, (China)[*2]Department of Hematology, The Second Affiliated Hospital of Soochow University, 1055 Sanxiang Road, Suzhou, Jiangsu,215004, (China)
推荐引用方式(GB/T 7714):
Bo Wang,Huan Yang,Liqin Shen,et al.Rs56288038 (C/G) in 3'UTR of IRF-1 Regulated by MiR-502-5p Promotes Gastric Cancer Development[J].CELLULAR PHYSIOLOGY AND BIOCHEMISTRY.2016,40(1-2):391-399.doi:10.1159/000452554.
APA:
Bo Wang,Huan Yang,Liqin Shen,Ji Wang,Wangyang Pu...&Zhixiang Zhuang.(2016).Rs56288038 (C/G) in 3'UTR of IRF-1 Regulated by MiR-502-5p Promotes Gastric Cancer Development.CELLULAR PHYSIOLOGY AND BIOCHEMISTRY,40,(1-2)
MLA:
Bo Wang,et al."Rs56288038 (C/G) in 3'UTR of IRF-1 Regulated by MiR-502-5p Promotes Gastric Cancer Development".CELLULAR PHYSIOLOGY AND BIOCHEMISTRY 40..1-2(2016):391-399